Study Completed

Acute Exacerbation Of Chronic Bronchitis, Community Acquired Pneumonia, Pelvic Inflammatory

Bayer Identifier:

11134

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Concentrations of moxifloxacin in gynecological tissues after single i.v. infusion of 400 mg in patients undergoing elective gynecological surgery

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

28 - 60 Years

Trial summary

Enrollment Goal

Trial Dates

July 2004 - May 2005

Phase

Phase 1

Could I Receive a placebo

N/A

Products

Avelox (Moxifloxacin hydrochloride, BAY12-8039)

Accepts Healthy Volunteer

N/A

Where to participate

Status	Institution	Location
Completed	Klinikum der Eberhard-Karls-Universität Tübingen	Tübingen, 72076, Germany
Completed	CRS Clinical-Research-Services Kiel GmbH	Kiel, 24105, Germany
Terminated	Klinikum der Eberhard-Karls-Universität Tübingen	Tübingen, 72076, Germany

Trial design

Concentrations of moxifloxacin in gynecological tissues after single intravenous infusion of 400 mg in patients undergoing elective gynecological surgery (single-dose, randomized, open-label, prospective, single-center study).

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.